United Guardian UG

NASDAQ UG
$9.15 +0.30 (+3.39%)
As of: Nov 10, 2026 · 9:57 AM EST

United Guardian (UG) stock price is $9.15, up 3.39% on the day, as of Nov 10, 2026. It has a market cap of $41.44Mn and a P/E ratio of 16.81, and is classified in the Pharmaceuticals industry (Healthcare sector).

Key Stats
Market Cap41.44 Mn
P/E16.81
FCF (Yr)1.91 Mn
ROA (Yr)15.65
EV to EBIT2.97
Net Income (Yr)2.11 Mn
Enterprise Value6.93 Mn
Add ratio to table…

About

United-Guardian, Inc. is a Delaware corporation that manufactures markets and develops specialty cosmetic personal care and sexual wellness ingredients as well as a line of healthcare products including pharmaceuticals and medical lubricants. The company traces its origins to United International Research Inc founded in 1942 by Dr Alfred R Globus and later merged with Guardian Chemical Corporation to become United-Guardian, Inc. All products except Renacidin are produced at…

Read more ↓
Sectors: Healthcare Basic Materials Sector rationale The primary sector is Healthcare because pharmaceutical products account for the largest portion of revenue (51%), including the FDA-approved drug Renacidin, and the company sells medical lubricants to medical device manufacturers. A secondary sector of Basic Materials is justified because the company also manufactures and sells specialty cosmetic and personal care ingredients (29% of sales) to other manufacturers via distributors like Brenntag and Ashland. Industries: Pharmaceuticals Pharmaceuticals Primary The company's largest revenue stream (51%) comes from pharmaceutical products, specifically Renacidin, which is an FDA-approved drug for preventing and dissolving urethral catheter calcifications. Specialty Chemicals Specialty Chemicals Secondary The company manufactures and sells specialty cosmetic and sexual wellness ingredients, which account for approximately 29% of sales, through distributors like Ashland Specialty Ingredients and Brenntag Specialties. Medical Supplies Medical Supplies Secondary The company produces medical lubricants sold directly to manufacturers of medical devices, such as catheter and surgical instrument producers, which accounts for 20% of total sales. Classified using BQ-MICS CIK: 0000101295

Geographical Breakdown of Revenue (2025)

History

Product and Service Breakdown of Revenue (2025)

History
Peer percentiles

How United Guardian ranks

Ranked against the 671 companies in Pharmaceuticals and Biotechnology58 metrics · as of Nov 6, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/E 12.7xMedian 17.8x 95th
  • P/FCF 9.19xMedian 21.0x 96th
  • P/Operating cash flow 9.01xMedian 16.8x 96th
  • P/S 2.79xMedian 8.14x 73rd
  • P/B 2.69xMedian 2.02x 41st
  • P/Tangible book 2.69xMedian 2.24x 44th
  • EV/EBITDA 8.84xMedian 15.7x 94th
  • EV/EBIT 9.28xMedian 20.9x 96th
  • EV/Revenue 1.93xMedian 5.92x 75th
  • EV/FCF 6.37xMedian 22.0x 97th
  • EV/Operating cash flow 6.25xMedian 18.3x 97th
  • PEG (3Y EPS CAGR) —Median 0.36 No data —
Peer group

Peer Comparison

Companies in the Pharmaceuticals
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 LLY ELI LILLY & Co 1,260.38 Bn45.7014.5849.50 Bn
2 JNJ Johnson & Johnson 676.03 Bn42.006.8144.65 Bn
3 ABBV AbbVie Inc. 516.05 Bn49.907.8280.90 Bn
4 MRK Merck & Co., Inc. 362.33 Bn147.715.3853.78 Bn
5 NVS Novartis Ag 315.38 Bn24.516.029.59 Bn
6 AZN Astrazeneca Plc 289.22 Bn33.245.3432.35 Bn
7 AMGN Amgen Inc 249.32 Bn26.556.4154.01 Bn
8 UG United Guardian Inc 0.04 Bn16.813.70-